Breakthrough Computational Study Targets Viral Kinases in Poxviridae Family
Researchers have developed an innovative AI-driven pipeline that combines structural bioinformatics with drug repurposing strategies to identify potential inhibitors against kinases encoded by viruses in the Poxviridae family. The work focuses on lumpy skin disease virus (LSDV), a significant pathogen in cattle, while highlighting broader applicability to related threats such as monkeypox and smallpox.
The study, published in Computers in Biology and Medicine, demonstrates how deep learning tools like AlphaFold2 and ESMFold can accelerate the discovery of antiviral candidates by predicting high-confidence protein structures even when experimental data is unavailable. This approach addresses a critical gap in antiviral development for emerging zoonotic diseases.
Understanding Poxviridae and the Need for New Antiviral Strategies
Poxviridae represents a family of large, double-stranded DNA viruses that includes several notable pathogens. LSDV causes lumpy skin disease, leading to skin nodules, fever, and substantial economic losses in livestock industries worldwide. Other members, such as monkeypox virus, have shown increasing human transmission, while the eradicated variola virus responsible for smallpox underscores the importance of maintaining preparedness against potential re-emergence or engineered threats.
These viruses encode their own protein kinases, enzymes that regulate phosphorylation events critical for viral replication, host cell interaction, and immune evasion. Because kinases are well-established drug targets in human medicine, repurposing existing inhibitors offers a faster path to new therapies compared to de novo drug development.
The AI-Enabled Structural Bioinformatics Pipeline
The research team built a comprehensive workflow that begins with genome mining and sequence conservation analysis across Poxviridae members. They identified two conserved kinases in LSDV: a serine/threonine kinase (LSTK) and a tyrosine kinase (LYK). Structural models were generated using AlphaFold2 and ESMFold, achieving high confidence scores with pLDDT values exceeding 85 and pTM scores around 0.85 to 0.88.
Models underwent rigorous validation through Ramachandran plot analysis and ERRAT quality assessments. Active sites were mapped, followed by virtual screening of 88 FDA-approved kinase inhibitors. Molecular docking and extensive molecular dynamics simulations evaluated binding stability, with binding free energy calculations confirming promising candidates. Cheminformatics profiling, including principal component analysis of physicochemical properties, assessed translational potential by comparing inhibitor chemical space with approved veterinary antivirals.
Key Findings: Lapatinib Emerges as a Leading Candidate
Among the screened compounds, lapatinib demonstrated strong potential as a competitive inhibitor of LSTK, showing stable occupancy of the ATP-binding site and favorable energetic profiles during simulations. Pazopanib also appeared as a notable binder. The analysis suggests these drugs could displace ATP and disrupt kinase function in the viral protein.
Importantly, the pipeline revealed significant conservation of the kinase domains across related poxviruses, including homologs in monkeypox virus. This conservation supports the idea that findings may extend beyond LSDV to other family members, providing a foundation for broader antiviral strategies in both veterinary and human health contexts.
Photo by Google DeepMind on Unsplash
Implications for Veterinary Medicine and Zoonotic Preparedness
Lumpy skin disease outbreaks have caused considerable economic damage in affected regions, particularly in Africa, the Middle East, and parts of Europe and Asia. Effective antivirals could complement existing vaccination efforts and help contain spread. The overlap in chemical space between kinase inhibitors and cattle-approved antivirals supports feasibility for veterinary applications.
From a public health perspective, the modular nature of the workflow makes it adaptable for rapid response to new or re-emerging poxviral threats. Researchers emphasize its generalizability, noting potential relevance for monkeypox preparedness amid ongoing global surveillance efforts.
Role of Artificial Intelligence in Modern Drug Discovery
Traditional experimental structure determination remains time-consuming and resource-intensive, especially for viral proteins. AI-based prediction tools have transformed the field by delivering reliable models in hours rather than months. This study exemplifies how integrating these predictions with established bioinformatics techniques—phylogenetics, docking, and dynamics—can yield actionable insights without initial wet-lab requirements.
The approach aligns with growing trends in computational biomedicine, where interdisciplinary teams leverage machine learning to prioritize targets and candidates before committing to expensive experimental validation.
Future Directions and Experimental Validation Needs
While the in silico results are promising, the authors note that experimental confirmation through in vitro binding assays and cell-based antiviral testing will be essential next steps. They also generated a combinatorial analog library to guide future chemical synthesis and optimization efforts.
Funding acknowledgments highlight support from India's Science and Engineering Research Board (SERB), reflecting national investment in computational approaches to infectious disease challenges. The work was conducted at institutions including CSIR-IICT, underscoring the role of established research organizations in advancing such projects.
Opportunities for Researchers in Bioinformatics and Virology
Studies like this open doors for early-career scientists interested in interdisciplinary fields. Skills in structural biology, machine learning applications, and virology are increasingly valued in academic and industry settings. Professionals with expertise in these areas contribute to both fundamental understanding and practical solutions for global health threats.
Academic institutions worldwide continue to expand programs and positions focused on computational biology, creating pathways for PhD graduates and postdoctoral researchers to engage with cutting-edge antiviral discovery projects.
Connecting Computational Advances to Academic Career Pathways
The success of AI-enabled pipelines highlights growing demand for researchers who can bridge data science and life sciences. Universities and research institutes actively recruit faculty and staff with combined expertise in these domains, supporting collaborative environments where such innovative work thrives.
Resources available through platforms like AcademicJobs.com help connect qualified candidates with relevant opportunities in research-intensive institutions, facilitating the next generation of discoveries in structural bioinformatics and infectious disease.
Broader Context: AI in Structural Biology and Antiviral Research
Similar computational strategies have proven valuable in other viral contexts, accelerating target identification when traditional methods lag. The integration of conservation analysis, structure prediction, and dynamics simulations provides a reproducible template that other teams can adapt for different pathogens.
This publication adds to the expanding literature demonstrating how repurposing existing pharmaceuticals can address urgent needs in veterinary and human medicine, particularly for families of viruses with conserved but understudied targets.
